Trending Topics

Loading trending topics...

See what’s trending right now
OPEC oil productionin Financial Markets
10 hours ago

Canada may see a new oil pipeline soon, while Saudi Arabia's unexpected price hikes and a surprising August output boost signal strong market confidence and shifting dynamics in the oil industry.

HomeFinancial MarketsAI in Healthcare
Financial Markets
Google DeepMind has grand ambitions to ‘cure all diseases’ with AI. Now, it’s gearing up for its first human trials
positiveFinancial Markets
Google DeepMind isn't just playing around with AI—it's aiming to revolutionize medicine. Through its spin-off, Isomorphic Labs, the team wants to use artificial intelligence to design drugs for diseases at the click of a button. Now, they're taking their first big step by preparing for human trials. It’s a moonshot goal, but if it works, it could change healthcare forever.
Editor’s Note: This isn’t just another tech headline—it’s a glimpse at a future where AI could drastically speed up drug discovery, potentially saving countless lives. If successful, this could mean faster, cheaper treatments for diseases that currently take years (or decades) to tackle. Of course, it’s early days, but the ambition alone is a big deal.

Why World Pulse Now?

Global Coverage

All major sources, one page

Emotional Lens

Feel the mood behind headlines

Trending Topics

Know what’s trending, globally

Read Less, Know More

Get summaries. Save time

Stay informed, save time
Learn more

Live Stats

Articles Processed

8,422

Trending Topics

120

Sources Monitored

211

Last Updated

in 6 hours

Live data processing
How it works

Mobile App

Get instant summaries, explore trending stories, and dive deeper into the headlines — all in one sleek, noise-free mobile experience.

Get it on Google PlayDownload on the App Store
Coming soon on iOS and Android.

1-Minute Daily Briefing

Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more

By subscribing, you agree to our Privacy Policy